ArticleBlood2021

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

Jithma P Abeykoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.